<i>Plasmodium falciparum</i> field isolates drug susceptibility in Mali
While current frontline therapies remain effective, reduced activity of chemopreventive antimalarials supports the need for continued surveillance to detect early signs of resistance in Mali. The potent activity of next-generation candidates (cabamiquine and GNF179) supports their potential for further clinical development and field deployment.
Authors
- Fatoumata Diallo (ORCID: https://orcid.org/0000-0002-1423-3417)
- Fanta Sogore
- François Dao (ORCID: https://orcid.org/0000-0003-4925-6093)
- Mohamed Lamine Alhousseini
- Ousmaila Diakité
- Niawanlou Dara
- Laurent Dembélé (ORCID: https://orcid.org/0000-0001-9087-8439)
- Oumar Traoré
- M Maiga
- Fatoumata Ousmane Maiga
- Souleymane Dama
- Abdoulaye A Djimde
Institutions
- Université des Sciences, des Techniques et des Technologies de Bamako (ML)
- Instituto de Medicina Genómica (ES)
Publication Details
- Journal
- JAC-Antimicrobial Resistance
- Published
- 2026-01-07
- DOI
- https://doi.org/10.1093/jacamr/dlag015
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.00